Bhutan vs Myanmar: Access to anti-retroviral drugs, female
Bhutan
80.0%
in 2024
Myanmar
78.0%
in 2024
Bhutan rank
57th
Myanmar rank
60th
Access to anti-retroviral drugs, female over time
- Bhutan
- Myanmar
How they compare
Bhutan currently reports 80.0% against 78.0% in Myanmar, a difference of 2.0%.
The two have swapped places 3 times across 25 shared years of data; in 2000 it was Myanmar ahead.
Bhutan ranks 57th and Myanmar ranks 60th of 141 countries.
Across the 3 decades both report, Bhutan averaged higher in 2 and Myanmar in 1.
Head to head by decade
| Decade | Bhutan | Myanmar | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 4.0% | 2.5% | 1.5% | Bhutan |
| 2010s | 46.2% | 39.2% | 7.0% | Bhutan |
| 2020s | 74.8% | 75.6% | 0.8% | Myanmar |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher access to anti-retroviral drugs, female, Bhutan or Myanmar?
- Bhutan, at 80.0% against 78.0% in Myanmar as of 2024.
- What is the difference in access to anti-retroviral drugs, female between Bhutan and Myanmar?
- 2.0%, with Bhutan ahead.
- How many years of comparable data are there for Bhutan and Myanmar?
- 25 years are reported by both, from 2000 to 2024.
- How do Bhutan and Myanmar rank globally for access to anti-retroviral drugs, female?
- Bhutan ranks 57th and Myanmar ranks 60th of 141 countries.
- Where does this data come from?
- UNAIDS estimates, published as Access to anti-retroviral drugs, female (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The percentage of adult females living with HIV who are receiving antiretroviral therapy.